FDA Inspection
Aurobindo Pharma LimitedAurobindo Pharma Limited – FDA Inspection, Sep 27, 2019
Record Details
This FDA Inspection record concerns Aurobindo Pharma Limited, with an inspection on September 27, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 65ccbba1-8a36-41aa-99c4-64321edccdd9
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1105823
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Aurobindo Pharma Limited
8| Date | Classification | Office | Project area |
|---|---|---|---|
| February 10, 2026 | Not classified | Office of Inspections and Investigations | |
| August 4, 2023 | Not classified | Office of Inspections and Investigations | |
| May 10, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 24, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 13, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Aurobindo Pharma Limited
- FDA Inspection 1304312 - 2026-02-10
- FDA Inspection 1242351 - 2023-08-04
- FDA Inspection 1169446 - 2022-05-10
- FDA Inspection 1022788 - 2017-06-24
- FDA Inspection 927596 - 2015-03-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.